Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Nature Neuroscience
|
November 8, 2016
A neuronal PI(3,4,5)P<sub>3</sub>-dependent program of oligodendrocyte precursor recruitment and myelination
Sandra Goebbels, Georg L Wieser, Alexander Pieper, et al.
Cell
|
October 18, 2023
Massively parallel functional dissection of schizophrenia-associated noncoding genetic variants
Christine K Rummel, Miriam Gagliardi, Ruhel Ahmad, et al.
EMBO Molecular Medicine
|
July 27, 2017
Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice
Michael C Wehr, Wilko Hinrichs, Magdalena M Brzózka, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2014
Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth
Hung-En Hsia, Rohit Kumar, Rossella Luca, et al.
Translational Psychiatry
|
August 16, 2025
iPSC-modelling reveals genetic associations and morphological alterations of oligodendrocytes in schizophrenia
Man-Hsin Chang, Jan Benedikt Waldeck, Marius Stephan, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2024
Modulation of Neuronal Excitability and Plasticity by BHLHE41 Conveys Lithium Non-Responsiveness
Marius Stephan, Sergi Papiol, Mingyue Zhang, et al.
Schizophrenia Bulletin
|
April 19, 2021
Hyperactivity is a Core Endophenotype of Elevated Neuregulin-1 Signaling in Embryonic Glutamatergic Networks
Tilmann Götze, Maria Clara Soto-Bernardini, Mingyue Zhang, et al.
Translational Psychiatry
|
November 9, 2022
Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles
Mojtaba Oraki Kohshour, Nirmal R Kannaiyan, August Jernbom Falk, et al.
Cell Reports
|
August 19, 2014
Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity
Amit Agarwal, Mingyue Zhang, Irina Trembak-Duff, et al.
Contemporary Clinical Trials Communications
|
February 20, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
Alkomiet Hasan, Astrid Roeh, Stefan Leucht, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Nature Neuroscience
|
November 8, 2016
A neuronal PI(3,4,5)P<sub>3</sub>-dependent program of oligodendrocyte precursor recruitment and myelination
Sandra Goebbels, Georg L Wieser, Alexander Pieper, et al.
Cell
|
October 18, 2023
Massively parallel functional dissection of schizophrenia-associated noncoding genetic variants
Christine K Rummel, Miriam Gagliardi, Ruhel Ahmad, et al.
EMBO Molecular Medicine
|
July 27, 2017
Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice
Michael C Wehr, Wilko Hinrichs, Magdalena M Brzózka, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2014
Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth
Hung-En Hsia, Rohit Kumar, Rossella Luca, et al.
Translational Psychiatry
|
August 16, 2025
iPSC-modelling reveals genetic associations and morphological alterations of oligodendrocytes in schizophrenia
Man-Hsin Chang, Jan Benedikt Waldeck, Marius Stephan, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2024
Modulation of Neuronal Excitability and Plasticity by BHLHE41 Conveys Lithium Non-Responsiveness
Marius Stephan, Sergi Papiol, Mingyue Zhang, et al.
Schizophrenia Bulletin
|
April 19, 2021
Hyperactivity is a Core Endophenotype of Elevated Neuregulin-1 Signaling in Embryonic Glutamatergic Networks
Tilmann Götze, Maria Clara Soto-Bernardini, Mingyue Zhang, et al.
Translational Psychiatry
|
November 9, 2022
Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles
Mojtaba Oraki Kohshour, Nirmal R Kannaiyan, August Jernbom Falk, et al.
Cell Reports
|
August 19, 2014
Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity
Amit Agarwal, Mingyue Zhang, Irina Trembak-Duff, et al.
Contemporary Clinical Trials Communications
|
February 20, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
Alkomiet Hasan, Astrid Roeh, Stefan Leucht, et al.
Page
of 10